BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1043 related articles for article (PubMed ID: 34425197)

  • 21. Proteome wide vaccine targets prioritization and designing of antigenic vaccine candidate to trigger the host immune response against the Mycoplasma genitalium infection.
    Ali S; Ali S; Javed SO; Shoukat S; Ahmad S; Ali SS; Hussain Z; Waseem M; Rizwan M; Suleman M; Khan A; Wei DQ
    Microb Pathog; 2021 Mar; 152():104771. PubMed ID: 33524568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A subtractive proteomics and immunoinformatics approach towards designing a potential multi-epitope vaccine against pathogenic Listeriamonocytogenes.
    Rahman S; Das AK
    Microb Pathog; 2022 Nov; 172():105782. PubMed ID: 36150556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants.
    Campos DMO; Silva MKD; Barbosa ED; Leow CY; Fulco UL; Oliveira JIN
    Comput Biol Chem; 2022 Dec; 101():107754. PubMed ID: 36037724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multi-epitope subunit vaccine based on CU/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB/C mice.
    Wang Y; Wu A; Xu Z; Zhang H; Li H; Fu S; Liu Y; Cui L; Miao Y; Wang Y; Zhumanov K; Xu Y; Sheng J; Yi J; Chen C
    Int Immunopharmacol; 2024 Jan; 127():111351. PubMed ID: 38113688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
    Jakhar R; Kaushik S; Gakhar SK
    J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii.
    Solanki V; Tiwari V
    Sci Rep; 2018 Jun; 8(1):9044. PubMed ID: 29899345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of Influenza A virus.
    Sharma S; Kumari V; Kumbhar BV; Mukherjee A; Pandey R; Kondabagil K
    Immunobiology; 2021 Mar; 226(2):152053. PubMed ID: 33517154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against
    Kumar A; Sharma P; Arun A; Meena LS
    J Biomol Struct Dyn; 2023 May; 41(8):3382-3404. PubMed ID: 35293852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analyses.
    Mahmoodi S; Amirzakaria JZ; Ghasemian A
    PLoS One; 2023; 18(5):e0285177. PubMed ID: 37146081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico design of a broad-spectrum multiepitope vaccine against influenza virus.
    Yuan L; Li X; Li M; Bi R; Li Y; Song J; Li W; Yan M; Luo H; Sun C; Shu Y
    Int J Biol Macromol; 2024 Jan; 254(Pt 3):128071. PubMed ID: 37967595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
    Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
    Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MERS virus spike protein HTL-epitopes selection and multi-epitope vaccine design using computational biology.
    Joshi A; Akhtar N; Sharma NR; Kaushik V; Borkotoky S
    J Biomol Struct Dyn; 2023; 41(22):12464-12479. PubMed ID: 36935104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An immunoinformatics and structural vaccinology study to design a multi-epitope vaccine against Staphylococcus aureus infection.
    Chatterjee R; Mahapatra SR; Dey J; Raj Takur K; Raina V; Misra N; Suar M
    J Mol Recognit; 2023 Apr; 36(4):e3007. PubMed ID: 36700877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunoinformatics approach for design and validation of multi-subunit vaccine against Cryptosporidium parvum.
    Dhal AK; Pani A; Mahapatra RK; Yun SI
    Immunobiology; 2019 Nov; 224(6):747-757. PubMed ID: 31522782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a novel multi‑epitope vaccine against the pathogenic human polyomavirus V6/7 using reverse vaccinology.
    Salahlou R; Farajnia S; Bargahi N; Bakhtiyari N; Elmi F; Shahgolzari M; Fiering S; Venkataraman S
    BMC Infect Dis; 2024 Feb; 24(1):177. PubMed ID: 38336665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling mRNA-based vaccine YFV.E1988 against yellow fever virus E-protein using immuno-informatics and reverse vaccinology approach.
    Khan NT; Zinnia MA; Islam ABMMK
    J Biomol Struct Dyn; 2023 Mar; 41(5):1617-1638. PubMed ID: 34994279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches.
    Huang S; Zhang C; Li J; Dai Z; Huang J; Deng F; Wang X; Yue X; Hu X; Li Y; Deng Y; Wang Y; Zhao W; Zhong Z; Wang Y
    Front Immunol; 2022; 13():933594. PubMed ID: 36439191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoinformatic based designing of potential immunogenic novel mRNA and peptide-based prophylactic vaccines against H5N1 and H7N9 avian influenza viruses.
    Ghafoor D; Zeb A; Ali SS; Ali M; Akbar F; Ud Din Z; Ur Rehman S; Suleman M; Khan W
    J Biomol Struct Dyn; 2024 Apr; 42(7):3641-3658. PubMed ID: 37222664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis.
    Jiang F; Liu Y; Xue Y; Cheng P; Wang J; Lian J; Gong W
    Int Immunopharmacol; 2023 Feb; 115():109728. PubMed ID: 36652758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.